Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Use of viral load to improve survey estimates of known HIV-positive status and antiretroviral treatment coverage.

Young PW, Zielinski-Gutierrez E, Wamicwe J, Mukui I, Kim AA, Waruru A, Zeh C, Kretzschmar ME, De Cock KM.

AIDS. 2019 Dec 2. doi: 10.1097/QAD.0000000000002453. [Epub ahead of print]

PMID:
31794520
2.

Noncommunicable disease burden among HIV patients in care: a national retrospective longitudinal analysis of HIV-treatment outcomes in Kenya, 2003-2013.

Achwoka D, Waruru A, Chen TH, Masamaro K, Ngugi E, Kimani M, Mukui I, Oyugi JO, Mutave R, Achia T, Katana A, Ng'ang'a L, De Cock KM.

BMC Public Health. 2019 Apr 3;19(1):372. doi: 10.1186/s12889-019-6716-2.

3.

Training health care providers to provide PrEP for HIV serodiscordant couples attending public health facilities in Kenya.

Irungu EM, Ngure K, Mugwanya K, Mugo N, Bukusi E, Wamoni E, Odoyo J, Morton JF, Bernabee G, Mambo B, Masyuko S, Mukui I, O'Malley G, Baeten JM.

Glob Public Health. 2019 Oct;14(10):1524-1534. doi: 10.1080/17441692.2019.1588908. Epub 2019 Mar 14.

PMID:
30871413
4.

'I saw it as a second chance': A qualitative exploration of experiences of treatment failure and regimen change among people living with HIV on second- and third-line antiretroviral therapy in Kenya, Malawi and Mozambique.

Burns R, Borges J, Blasco P, Vandenbulcke A, Mukui I, Magalasi D, Molfino L, Manuel R, Schramm B, Wringe A.

Glob Public Health. 2019 Aug;14(8):1112-1124. doi: 10.1080/17441692.2018.1561921. Epub 2019 Jan 11.

5.

Disclosure and Clinical Outcomes Among Young Adolescents Living With HIV in Kenya.

Ngeno B, Waruru A, Inwani I, Nganga L, Wangari EN, Katana A, Gichangi A, Mwangi A, Mukui I, Rutherford GW.

J Adolesc Health. 2019 Feb;64(2):242-249. doi: 10.1016/j.jadohealth.2018.08.013. Epub 2018 Oct 25.

6.

Pre-exposure prophylaxis rollout in a national public sector program: the Kenyan case study.

Masyuko S, Mukui I, Njathi O, Kimani M, Oluoch P, Wamicwe J, Mutegi J, Njogo S, Anyona M, Muchiri P, Maikweki L, Musyoki H, Bahati P, Kyongo J, Marwa T, Irungu E, Kiragu M, Kioko U, Ogando J, Were D, Bartilol K, Sirengo M, Mugo N, Baeten JM, Cherutich P, PrEP Technical Working Group OBOT.

Sex Health. 2018 Nov;15(6):578-586. doi: 10.1071/SH18090.

PMID:
30408432
7.

Equity of antiretroviral treatment use in high HIV burden countries: Analyses of data from nationally-representative surveys in Kenya and South Africa.

Moyo S, Young PW, Gouws E, Naidoo I, Wamicwe J, Mukui I, Marsh K, Igumbor EU, Kim AA, Rehle T.

PLoS One. 2018 Aug 10;13(8):e0201899. doi: 10.1371/journal.pone.0201899. eCollection 2018.

8.

Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya.

Pilgrim NA, Okal J, Matheka J, Mukui I, Kalibala S.

BMC Pediatr. 2018 Jul 25;18(1):243. doi: 10.1186/s12887-018-1209-5.

9.

Characteristics of Treatment-experienced HIV-infected African Children and Adolescents Initiating Darunavir and/or Etravirine-based Antiretroviral Treatment.

Corrigan B, Mukui I, Mulenga L, Mthethwa N, Letsie M, Bruno S, Rakhmanina N.

Pediatr Infect Dis J. 2018 Jul;37(7):669-672. doi: 10.1097/INF.0000000000001843.

PMID:
29140932
10.

Low levels of viral suppression among refugees and host nationals accessing antiretroviral therapy in a Kenyan refugee camp.

Mendelsohn JB, Spiegel P, Grant A, Doraiswamy S, Schilperoord M, Larke N, Burton JW, Okonji JA, Zeh C, Muhindo B, Mohammed IM, Mukui IN, Patterson N, Sondorp E, Ross DA.

Confl Health. 2017 May 31;11:11. doi: 10.1186/s13031-017-0111-3. eCollection 2017.

11.

Pediatric Treatment Scale-Up: The Unfinished Agenda of the Global Plan.

Penazzato M, Amzel A, Abrams EJ, Kiragu K, Essajee S, Mukui I, Elyanu P, Rwebembera AA, Mbori-Ngacha D.

J Acquir Immune Defic Syndr. 2017 May 1;75 Suppl 1:S59-S65. doi: 10.1097/QAI.0000000000001333. Review.

PMID:
28398998
12.

Emergence of untreatable, multidrug-resistant HIV-1 in patients failing second-line therapy in Kenya.

Inzaule SC, Hamers RL, Mukui I, Were K, Owiti P, Kwaro D, Rinke de Wit TF, Zeh C.

AIDS. 2017 Jun 19;31(10):1495-1498. doi: 10.1097/QAD.0000000000001500.

PMID:
28398959
13.

High Prevalence of Abacavir-associated L74V/I Mutations in Kenyan Children Failing Antiretroviral Therapy.

Dziuban EJ, DeVos J, Ngeno B, Ngugi E, Zhang G, Sabatier J, Wagar N, Diallo K, Nganga L, Katana A, Yang C, Rivadeneira ED, Mukui I, Odhiambo F, Redfield R, Raizes E.

Pediatr Infect Dis J. 2017 Aug;36(8):758-760. doi: 10.1097/INF.0000000000001597.

14.

Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.

Onywera H, Maman D, Inzaule S, Auma E, Were K, Fredrick H, Owiti P, Opollo V, Etard JF, Mukui I, Kim AA, Zeh C.

PLoS One. 2017 Feb 8;12(2):e0171124. doi: 10.1371/journal.pone.0171124. eCollection 2017.

15.

Field Evaluation of Dried Blood Spots for HIV-1 Viral Load Monitoring in Adults and Children Receiving Antiretroviral Treatment in Kenya: Implications for Scale-up in Resource-Limited Settings.

Schmitz ME, Agolory S, Junghae M, Broyles LN, Kimeu M, Ombayo J, Umuro M, Mukui I, Alwenya K, Baraza M, Ndiege K, Mwalili S, Rivadeneira E, Ngʼangʼa L, Yang C, Zeh C; for VL-DBS Study Group.

J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):399-406. doi: 10.1097/QAI.0000000000001275.

PMID:
28002185
16.

Rates and Predictors of Non-Adherence to Antiretroviral Therapy among HIV-Positive Individuals in Kenya: Results from the Second Kenya AIDS Indicator Survey, 2012.

Mukui IN, Ng'ang'a L, Williamson J, Wamicwe JN, Vakil S, Katana A, Kim AA.

PLoS One. 2016 Dec 1;11(12):e0167465. doi: 10.1371/journal.pone.0167465. eCollection 2016.

17.

Undisclosed HIV infection and antiretroviral therapy use in the Kenya AIDS indicator survey 2012: relevance to national targets for HIV diagnosis and treatment.

Kim AA, Mukui I, Young PW, Mirjahangir J, Mwanyumba S, Wamicwe J, Bowen N, Wiesner L, Ng'ang'a L, De Cock KM; KAIS Study Group.

AIDS. 2016 Nov 13;30(17):2685-2695.

18.

Retention in Care Among HIV-infected Patients Receiving or Not Receiving Antiretroviral Therapy in Eastern Africa.

Reidy W, Agarwal M, Chege D, Lamb M, Hawken M, Mukui I, Abrams E, Geng E.

Clin Infect Dis. 2016 Aug 1;63(3):426-7. doi: 10.1093/cid/ciw302. Epub 2016 May 10. No abstract available.

19.

Potential impact of multiple interventions on HIV incidence in a hyperendemic region in Western Kenya: a modelling study.

Blaizot S, Maman D, Riche B, Mukui I, Kirubi B, Ecochard R, Etard JF.

BMC Infect Dis. 2016 Apr 29;16:189. doi: 10.1186/s12879-016-1520-4.

20.

Progress in Reversing the HIV Epidemic through Intensified Access to Antiretroviral Therapy: Results from a Nationally Representative Population-Based Survey in Kenya, 2012.

Kim AA, Mukui I, N'gan'ga L, Katana A, Koros D, Wamicwe J, De Cock KM; KAIS Study Group.

PLoS One. 2016 Mar 1;11(3):e0148068. doi: 10.1371/journal.pone.0148068. eCollection 2016.

21.

HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing.

Rhee SY, Jordan MR, Raizes E, Chua A, Parkin N, Kantor R, Van Zyl GU, Mukui I, Hosseinipour MC, Frenkel LM, Ndembi N, Hamers RL, Rinke de Wit TF, Wallis CL, Gupta RK, Fokam J, Zeh C, Schapiro JM, Carmona S, Katzenstein D, Tang M, Aghokeng AF, De Oliveira T, Wensing AM, Gallant JE, Wainberg MA, Richman DD, Fitzgibbon JE, Schito M, Bertagnolio S, Yang C, Shafer RW.

PLoS One. 2015 Dec 30;10(12):e0145772. doi: 10.1371/journal.pone.0145772. eCollection 2015.

22.

Cascade of HIV care and population viral suppression in a high-burden region of Kenya.

Maman D, Zeh C, Mukui I, Kirubi B, Masson S, Opolo V, Szumilin E, Riche B, Etard JF.

AIDS. 2015 Jul 31;29(12):1557-65. doi: 10.1097/QAD.0000000000000741.

23.

Estimation and Short-Term Prediction of the Course of the HIV Epidemic Using Demographic and Health Survey Methodology-Like Data.

Blaizot S, Riche B, Maman D, Mukui I, Kirubi B, Etard JF, Ecochard R.

PLoS One. 2015 Jun 19;10(6):e0130387. doi: 10.1371/journal.pone.0130387. eCollection 2015.

24.

Characteristics and outcomes of HIV-infected youth and young adolescents enrolled in HIV care in Kenya.

Koech E, Teasdale CA, Wang C, Fayorsey R, Alwar T, Mukui IN, Hawken M, Abrams EJ.

AIDS. 2014 Nov 28;28(18):2729-38. doi: 10.1097/QAD.0000000000000473.

25.

Engagement in HIV care among Kenyan adults and adolescents: results from a national population-based survey.

Wafula R, Masyuko S, Ng'ang'a L, Kim AA, Gichangi A, Mukui I, Batuka J, Ngugi EW, Maina WK, Schwarcz S; KAIS Study Group.

J Acquir Immune Defic Syndr. 2014 May 1;66 Suppl 1:S98-105. doi: 10.1097/QAI.0000000000000119.

26.

Burden of HIV infection among children aged 18 months to 14 years in Kenya: results from a nationally representative population-based cross-sectional survey.

Ng'eno B, Mwangi A, Ng'ang'a L, Kim AA, Waruru A, Mukui I, Ngugi EW, Rutherford GW; KAIS Study Group.

J Acquir Immune Defic Syndr. 2014 May 1;66 Suppl 1:S82-8. doi: 10.1097/QAI.0000000000000118.

27.

Antiretroviral treatment scale-up among persons living with HIV in Kenya: results from a nationally representative survey.

Odhiambo JO, Kellogg TA, Kim AA, Ng'ang'a L, Mukui I, Umuro M, Mohammed I, De Cock KM, Kimanga DO, Schwarcz S; KAIS Study Group.

J Acquir Immune Defic Syndr. 2014 May 1;66 Suppl 1:S116-22. doi: 10.1097/QAI.0000000000000122.

28.

Contraceptive practices and fertility desires among HIV-infected and uninfected women in Kenya: results from a nationally representative study.

Ngugi EW, Kim AA, Nyoka R, Ng'ang'a L, Mukui I, Ng'eno B, Rutherford GW; KAIS Study Group.

J Acquir Immune Defic Syndr. 2014 May 1;66 Suppl 1:S75-81. doi: 10.1097/QAI.0000000000000107.

Supplemental Content

Support Center